GLP-1 receptor agonists have become a cornerstone in the treatment of type 2 diabetes, offering several advantages over traditional therapies: Blood sugar control: GLP-1s effectively lower blood glucose levels, with an average reduction in hemoglobin A1c (HA1C) of about 1% compared to control groups
The genetic test reveals predispositions in key metabolic pathways that influence how efficiently your body synthesizes and recycles antioxidants, including glutathione
Semaglutide Treatment Effect in People with obesity (STEP) programme is to investigate the effect of semaglutide compared to placebo on weight loss, safety, and tolerability in adults with obesity or overweight
Choosing the right treatment for neurological or pain-related conditions requires clear information and professional advice
During treatment, the medication affects appetite regulation, fullness signals and energy balance
It's not about willpower or avoiding discomfort